Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of $320.03 million as of June 13, 2025. Its market cap has decreased by -39.48% in one year.

Market Cap

320.03M

Enterprise Value

191.45M

Revenue

56.33M

Ranking

n/a

PE Ratio

13.34

Stock Price

$7.22

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 2.79M to 320.03M, an increase of 11,374.93%. That is a compound annual growth rate of 21.51%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	320.03M	-14.15%
Dec 31, 2024	372.77M	-31.82%
Dec 29, 2023	546.72M	-24.87%
Dec 30, 2022	727.74M	-25.56%
Dec 31, 2021	977.57M	14.90%
Dec 31, 2020	850.82M	-13.85%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.62B
Veradigm	747.25M
Elite Pharmaceuticals	726.32M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	435.79M
Glass House Brands	396.26M
Northwest Biotherapeutics	380.63M

Market Cap Rankings